584 related articles for article (PubMed ID: 22293185)
1. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.
Ratushny V; Gober MD; Hick R; Ridky TW; Seykora JT
J Clin Invest; 2012 Feb; 122(2):464-72. PubMed ID: 22293185
[TBL] [Abstract][Full Text] [Related]
2. Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma.
Zou DD; Sun YZ; Li XJ; Wu WJ; Xu D; He YT; Qi J; Tu Y; Tang Y; Tu YH; Wang XL; Li X; Lu FY; Huang L; Long H; He L; Li X
Elife; 2023 Dec; 12():. PubMed ID: 38099574
[TBL] [Abstract][Full Text] [Related]
3. [Beyond actinic keratoses: Field cancerization of the skin].
Reygagne P; Rostain G
Ann Dermatol Venereol; 2018 Oct; 145(10):587-592. PubMed ID: 30243819
[TBL] [Abstract][Full Text] [Related]
4. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
5. Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
Rymsza A; Świerczyńska K; Piotrowska A; Dzięgiel P; Szepietowski JC
In Vivo; 2022; 36(3):1245-1251. PubMed ID: 35478139
[TBL] [Abstract][Full Text] [Related]
6. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
Zuo S; Li X; Bao W; Li S
Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
[TBL] [Abstract][Full Text] [Related]
7. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
8. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
[TBL] [Abstract][Full Text] [Related]
9. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
[TBL] [Abstract][Full Text] [Related]
10. Progression of skin lesions from normal skin to squamous cell carcinoma.
Krouse RS; Alberts DS; Prasad AR; Yozwiak M; Bartels HG; Liu Y; Bartels PH
Anal Quant Cytol Histol; 2009 Feb; 31(1):17-25. PubMed ID: 19320189
[TBL] [Abstract][Full Text] [Related]
11. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
[TBL] [Abstract][Full Text] [Related]
12. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
Karagece Yalçin U; Seçkın S
Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
[TBL] [Abstract][Full Text] [Related]
13. Genomic Progression of Precancerous Actinic Keratosis to Squamous Cell Carcinoma.
Kim YS; Shin S; Jung SH; Park YM; Park GS; Lee SH; Chung YJ
J Invest Dermatol; 2022 Mar; 142(3 Pt A):528-538.e8. PubMed ID: 34480890
[TBL] [Abstract][Full Text] [Related]
14. Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.
Xu G; Fang J; Xu J; Shen Z; Huang C; Jiang Y
Bioengineered; 2021 Dec; 12(2):9930-9938. PubMed ID: 34874800
[TBL] [Abstract][Full Text] [Related]
15. Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.
Dańczak-Pazdrowska A; Pazdrowski J; Polańska A; Basta B; Schneider A; Kowalczyk MJ; Golusiński P; Golusiński W; Adamski Z; Żaba R; Masternak MM
Arch Dermatol Res; 2022 Apr; 314(3):257-266. PubMed ID: 33813600
[TBL] [Abstract][Full Text] [Related]
16. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
Filosa A; Filosa G
G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
[TBL] [Abstract][Full Text] [Related]
17. The Genomic Landscape of Actinic Keratosis.
Thomson J; Bewicke-Copley F; Anene CA; Gulati A; Nagano A; Purdie K; Inman GJ; Proby CM; Leigh IM; Harwood CA; Wang J
J Invest Dermatol; 2021 Jul; 141(7):1664-1674.e7. PubMed ID: 33482222
[TBL] [Abstract][Full Text] [Related]
18. MART-1-labeled melanocyte density and distribution in actinic keratosis and squamous cell cancer in situ: Pagetoid melanocytes are a potential source of misdiagnosis as melanoma in situ.
Fix WC; Yun SJ; Groft MacFarlane CM; Jambusaria A; Elenitsas R; Chu E; Etzkorn JR; Sobanko JF; Shin TM; Miller CJ
J Cutan Pathol; 2018 Oct; 45(10):734-742. PubMed ID: 29943494
[TBL] [Abstract][Full Text] [Related]
19. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
[TBL] [Abstract][Full Text] [Related]
20. Subclonal Evolution of Cancer-Related Gene Mutations in p53 Immunopositive Patches in Human Skin.
Albibas AA; Rose-Zerilli MJJ; Lai C; Pengelly RJ; Lockett GA; Theaker J; Ennis S; Holloway JW; Healy E
J Invest Dermatol; 2018 Jan; 138(1):189-198. PubMed ID: 28844940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
